Publication: Polymorphisms in platelet glycoprotein 1b± and factor vii and risk of ischemic stroke: A meta-analysis
Issued Date
2008-06-01
Resource Type
ISSN
00392499
Other identifier(s)
2-s2.0-46249103285
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Stroke. Vol.39, No.6 (2008), 1710-1716
Suggested Citation
Jane M. Maguire, Ammarin Thakkinstian, Jon Sturm, Christopher Levi, Lisa Lincz, Mark Parsons, Scott Whyte, John Attia Polymorphisms in platelet glycoprotein 1b± and factor vii and risk of ischemic stroke: A meta-analysis. Stroke. Vol.39, No.6 (2008), 1710-1716. doi:10.1161/STROKEAHA.107.507228 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/19670
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Polymorphisms in platelet glycoprotein 1b± and factor vii and risk of ischemic stroke: A meta-analysis
Abstract
BACKGROUND AND PURPOSE: Platelets and components of the coagulation cascade are known to be instrumental in the pathogenesis of arterial occlusive disorders. The aim of this meta-analysis is to test the hypothesis that genetic variation in the platelet glycoprotein 1bα and Factor VII genes influence the occurrence of ischemic stroke. All genetic association studies that examined the R353Q (rs6046) polymorphism of the Factor VII gene and 2 polymorphisms of the platelet glycoprotein (1bα) gene (Thr/Met rs6065 and Kozak sequence ĝ̂'5 C/T rs2243093) in relation to ischemic stroke were examined. METHODS: Electronic databases Embase, Medline, and HuGEnet were searched for all years up until June 2006 for all studies that evaluated any of these candidate genes and stroke. RESULTS: Pooled ORs were calculated with 95% CIs using both fixed and random effects models. Meta-analysis for Factor VII (R353Q) did not detect any effect on ischemic stroke risk. Further estimation resulted in pooled OR1 QQ versus RR≤0.9 (95% CI: 0.4 to 1.9) and pooled OR2 for RQ versus RR≤0.9 (95% CI: 0.6 to 1.4). These results were robust and homogeneous. Pooling ORs for the platelet glycoprotein 1bα Kozak variant - 5 T/C polymorphism showed extreme heterogeneity with differing effect directions across studies. Fisher's method of pooling was therefore used to calculate a combined probability value, which was highly significant (P<0.001). The pooled OR for platelet glycoprotein 1bα Met/Met v Thr/Thr was 1.0 to 2.0, depending on the sensitivity analyses, and for Thr/Met versus Thr/Thr, the pooled OR was between 1.3 and 1.4. These results were consistent, reasonably robust, and implied a dominant genetic effect. CONCLUSION: This analysis provides strong evidence that the Factor VII R353Q gene polymorphism is not associated with ischemic stroke, that the Thr/Met polymorphism of GP1bα is associated with ischemic stroke in a dominant genetic model, and that the Kozak sequence polymorphism of GP1bα may be close to another causative locus that is associated with ischemic stroke. © 2008 American Heart Association, Inc.